Literature DB >> 7408241

Suppression of polyclonal immunoglobulins in multiple myeloma: relationship to the staging and other manifestations at diagnosis.

W Pruzanski, M S Gidon, A Roy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408241     DOI: 10.1016/0090-1229(80)90097-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  16 in total

Review 1.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

2.  Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma.

Authors:  E Kastritis; F Zagouri; A Symeonidis; M Roussou; A Sioni; A Pouli; S Delimpasi; E Katodritou; E Michalis; M Michael; E Hatzimichael; A Vassou; P Repousis; A Christophoridou; Z Kartasis; E Stefanoudaki; C Megalakaki; S Giannouli; M-C Kyrtsonis; K Konstantopoulos; M Spyroupoulou-Vlachou; E Terpos; M A Dimopoulos
Journal:  Leukemia       Date:  2014-03-18       Impact factor: 11.528

3.  Suppression of polyclonal B cell proliferation mediated by supernatants from human myeloma bone marrow cell cultures.

Authors:  D Peest; R Hölscher; R Weber; R Leo; H Deicher
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

4.  Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients.

Authors:  L M Pilarski; M J Mant; B A Ruether; A Belch
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.

Authors:  C D Platsoucas; H J Hansen; J R Redman; S Berenson; B J Lee; B D Clarkson
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

6.  Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function.

Authors:  L M Pilarski; E J Andrews; M J Mant; B A Ruether
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

7.  Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.

Authors:  L M Pilarski; B A Ruether; M J Mant
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

8.  Effects of cefodizime on non-specific immune functions in patients with multiple myeloma.

Authors:  F Dammacco; S Benvestito
Journal:  Infection       Date:  1992       Impact factor: 3.553

9.  Defective monocyte chemotactic responsiveness in patients with multiple myeloma and benign monoclonal gammapathy.

Authors:  F Dammacco; A Miglietta; M T Ventura; L Bonomo
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

10.  Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.

Authors:  Rajshekhar Chakraborty; Lisa Rybicki; Megan O Nakashima; Robert M Dean; Beth M Faiman; Christy J Samaras; Nathaniel Rosko; Hayley Dysert; Jason Valent; Faiz Anwer
Journal:  Br J Haematol       Date:  2020-02-28       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.